학술논문

Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study
Document Type
Article
Source
In: Oncologist. (Oncologist, 1 November 2019, 24(11):1424-1431)
Subject
Language
English
ISSN
1549490X
10837159